8-119732053-C-T

Variant summary

Our verdict is Benign. Variant got -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBS1BS2

The NM_003184.4(TAF2):​c.3471G>A​(p.Lys1157Lys) variant causes a synonymous change. The variant allele was found at a frequency of 0.0192 in 1,614,052 control chromosomes in the GnomAD database, including 387 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.016 ( 31 hom., cov: 32)
Exomes 𝑓: 0.020 ( 356 hom. )

Consequence

TAF2
NM_003184.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 6.30
Variant links:
Genes affected
TAF2 (HGNC:11536): (TATA-box binding protein associated factor 2) Initiation of transcription by RNA polymerase II requires the activities of more than 70 polypeptides. The protein that coordinates these activities is transcription factor IID (TFIID), which binds to the core promoter to position the polymerase properly, serves as the scaffold for assembly of the remainder of the transcription complex, and acts as a channel for regulatory signals. TFIID is composed of the TATA-binding protein (TBP) and a group of evolutionarily conserved proteins known as TBP-associated factors or TAFs. TAFs may participate in basal transcription, serve as coactivators, function in promoter recognition or modify general transcription factors (GTFs) to facilitate complex assembly and transcription initiation. This gene encodes one of the larger subunits of TFIID that is stably associated with the TFIID complex. It contributes to interactions at and downstream of the transcription initiation site, interactions that help determine transcription complex response to activators. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -18 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.22).
BP6
Variant 8-119732053-C-T is Benign according to our data. Variant chr8-119732053-C-T is described in ClinVar as [Benign]. Clinvar id is 1169029.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.0157 (2384/152242) while in subpopulation NFE AF= 0.0228 (1548/68020). AF 95% confidence interval is 0.0218. There are 31 homozygotes in gnomad4. There are 1142 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 31 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
TAF2NM_003184.4 linkc.3471G>A p.Lys1157Lys synonymous_variant 26/26 ENST00000378164.7 NP_003175.2 Q6P1X5B3KMD8

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
TAF2ENST00000378164.7 linkc.3471G>A p.Lys1157Lys synonymous_variant 26/261 NM_003184.4 ENSP00000367406.2 Q6P1X5
TAF2ENST00000686879.1 linkc.3627G>A p.Lys1209Lys synonymous_variant 27/27 ENSP00000509206.1 A0A8I5KV60
TAF2ENST00000685235.1 linkc.3516G>A p.Lys1172Lys synonymous_variant 26/26 ENSP00000510174.1 A0A8I5QJR0
TAF2ENST00000688645.1 linkc.3360G>A p.Lys1120Lys synonymous_variant 25/25 ENSP00000509978.1 A0A8I5KSY6
TAF2ENST00000523904.2 linkc.3357G>A p.Lys1119Lys synonymous_variant 25/253 ENSP00000430832.2 H0YC37
TAF2ENST00000690144 linkc.*602G>A 3_prime_UTR_variant 26/26 ENSP00000510548.1 A0A8I5KUQ2
TAF2ENST00000685202.1 linkn.*996G>A non_coding_transcript_exon_variant 27/27 ENSP00000509214.1 A0A8I5QJD7
TAF2ENST00000685503.1 linkn.*2863G>A non_coding_transcript_exon_variant 26/26 ENSP00000509198.1 A0A8I5KXS3
TAF2ENST00000685663.1 linkn.*3343G>A non_coding_transcript_exon_variant 28/28 ENSP00000508988.1 A0A8I5KUD2
TAF2ENST00000685684.1 linkn.*4938G>A non_coding_transcript_exon_variant 25/25 ENSP00000509441.1 A0A8I5KY57
TAF2ENST00000685824.1 linkn.*3172G>A non_coding_transcript_exon_variant 24/24 ENSP00000510262.1 A0A8I5KU60
TAF2ENST00000685876.1 linkn.*3189G>A non_coding_transcript_exon_variant 27/27 ENSP00000510493.1 A0A8I5KUD2
TAF2ENST00000685993.1 linkn.*3286G>A non_coding_transcript_exon_variant 25/25 ENSP00000510102.1 A0A8I5KU60
TAF2ENST00000686098.1 linkn.*2116G>A non_coding_transcript_exon_variant 25/25 ENSP00000509102.1 A0A8I5KXP3
TAF2ENST00000688037.1 linkn.*2890G>A non_coding_transcript_exon_variant 23/23 ENSP00000510169.1 A0A8I5KRI4
TAF2ENST00000689919.1 linkn.*3078G>A non_coding_transcript_exon_variant 26/26 ENSP00000510768.1 A0A8I5KUD2
TAF2ENST00000690808.1 linkn.*2707G>A non_coding_transcript_exon_variant 26/26 ENSP00000509791.1 A0A8I5KVC1
TAF2ENST00000690922.1 linkn.*1883G>A non_coding_transcript_exon_variant 26/26 ENSP00000509498.1 A0A8I5KPW0
TAF2ENST00000691880.1 linkn.*3127G>A non_coding_transcript_exon_variant 25/25 ENSP00000508515.1 A0A8I5KNG3
TAF2ENST00000692518.1 linkn.*3337G>A non_coding_transcript_exon_variant 25/25 ENSP00000508959.1 A0A8I5KU60
TAF2ENST00000692707.1 linkn.*3339G>A non_coding_transcript_exon_variant 28/28 ENSP00000509024.1 A0A8I5KUD2
TAF2ENST00000692916.1 linkn.*2858G>A non_coding_transcript_exon_variant 25/25 ENSP00000509603.1 A0A8I5QJI9
TAF2ENST00000685202.1 linkn.*996G>A 3_prime_UTR_variant 27/27 ENSP00000509214.1 A0A8I5QJD7
TAF2ENST00000685503.1 linkn.*2863G>A 3_prime_UTR_variant 26/26 ENSP00000509198.1 A0A8I5KXS3
TAF2ENST00000685663.1 linkn.*3343G>A 3_prime_UTR_variant 28/28 ENSP00000508988.1 A0A8I5KUD2
TAF2ENST00000685684.1 linkn.*4938G>A 3_prime_UTR_variant 25/25 ENSP00000509441.1 A0A8I5KY57
TAF2ENST00000685824.1 linkn.*3172G>A 3_prime_UTR_variant 24/24 ENSP00000510262.1 A0A8I5KU60
TAF2ENST00000685876.1 linkn.*3189G>A 3_prime_UTR_variant 27/27 ENSP00000510493.1 A0A8I5KUD2
TAF2ENST00000685993.1 linkn.*3286G>A 3_prime_UTR_variant 25/25 ENSP00000510102.1 A0A8I5KU60
TAF2ENST00000686098.1 linkn.*2116G>A 3_prime_UTR_variant 25/25 ENSP00000509102.1 A0A8I5KXP3
TAF2ENST00000688037.1 linkn.*2890G>A 3_prime_UTR_variant 23/23 ENSP00000510169.1 A0A8I5KRI4
TAF2ENST00000689919.1 linkn.*3078G>A 3_prime_UTR_variant 26/26 ENSP00000510768.1 A0A8I5KUD2
TAF2ENST00000690808.1 linkn.*2707G>A 3_prime_UTR_variant 26/26 ENSP00000509791.1 A0A8I5KVC1
TAF2ENST00000690922.1 linkn.*1883G>A 3_prime_UTR_variant 26/26 ENSP00000509498.1 A0A8I5KPW0
TAF2ENST00000691880.1 linkn.*3127G>A 3_prime_UTR_variant 25/25 ENSP00000508515.1 A0A8I5KNG3
TAF2ENST00000692518.1 linkn.*3337G>A 3_prime_UTR_variant 25/25 ENSP00000508959.1 A0A8I5KU60
TAF2ENST00000692707.1 linkn.*3339G>A 3_prime_UTR_variant 28/28 ENSP00000509024.1 A0A8I5KUD2
TAF2ENST00000692916.1 linkn.*2858G>A 3_prime_UTR_variant 25/25 ENSP00000509603.1 A0A8I5QJI9
TAF2ENST00000689164.1 linkn.*4089G>A downstream_gene_variant ENSP00000508729.1 A0A8I5KR26

Frequencies

GnomAD3 genomes
AF:
0.0157
AC:
2383
AN:
152124
Hom.:
31
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00389
Gnomad AMI
AF:
0.0592
Gnomad AMR
AF:
0.0126
Gnomad ASJ
AF:
0.0533
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00269
Gnomad FIN
AF:
0.0188
Gnomad MID
AF:
0.0191
Gnomad NFE
AF:
0.0228
Gnomad OTH
AF:
0.0110
GnomAD3 exomes
AF:
0.0165
AC:
4158
AN:
251322
Hom.:
56
AF XY:
0.0164
AC XY:
2227
AN XY:
135820
show subpopulations
Gnomad AFR exome
AF:
0.00394
Gnomad AMR exome
AF:
0.00746
Gnomad ASJ exome
AF:
0.0568
Gnomad EAS exome
AF:
0.0000544
Gnomad SAS exome
AF:
0.00310
Gnomad FIN exome
AF:
0.0187
Gnomad NFE exome
AF:
0.0234
Gnomad OTH exome
AF:
0.0179
GnomAD4 exome
AF:
0.0196
AC:
28598
AN:
1461810
Hom.:
356
Cov.:
31
AF XY:
0.0191
AC XY:
13905
AN XY:
727200
show subpopulations
Gnomad4 AFR exome
AF:
0.00361
Gnomad4 AMR exome
AF:
0.00756
Gnomad4 ASJ exome
AF:
0.0582
Gnomad4 EAS exome
AF:
0.0000252
Gnomad4 SAS exome
AF:
0.00294
Gnomad4 FIN exome
AF:
0.0183
Gnomad4 NFE exome
AF:
0.0216
Gnomad4 OTH exome
AF:
0.0196
GnomAD4 genome
AF:
0.0157
AC:
2384
AN:
152242
Hom.:
31
Cov.:
32
AF XY:
0.0153
AC XY:
1142
AN XY:
74432
show subpopulations
Gnomad4 AFR
AF:
0.00388
Gnomad4 AMR
AF:
0.0126
Gnomad4 ASJ
AF:
0.0533
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00270
Gnomad4 FIN
AF:
0.0188
Gnomad4 NFE
AF:
0.0228
Gnomad4 OTH
AF:
0.0109
Alfa
AF:
0.0227
Hom.:
19
Bravo
AF:
0.0146
Asia WGS
AF:
0.00491
AC:
17
AN:
3478
EpiCase
AF:
0.0237
EpiControl
AF:
0.0255

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 30, 2024- -
Microcephaly-thin corpus callosum-intellectual disability syndrome Benign:1
Benign, criteria provided, single submitterclinical testingMolecular Genetics, Royal Melbourne HospitalMay 04, 2023European Non-Finnish population allele frequency is 2.261% (rs61753747, 2998/129026 alleles, 39 homozygotes in gnomAD v2.1). Based on the classification scheme RMH Modified ACMG/AMP Guidelines v1.2.1, this variant is classified as BENIGN. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.22
CADD
Benign
9.2
DANN
Benign
0.74

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs61753747; hg19: chr8-120744293; COSMIC: COSV65418236; COSMIC: COSV65418236; API